Allan C. Silber - 31 Dec 2021 Form 5/A - Amendment Insider Report for POINT Biopharma Global Inc.

Role
Executive Chairman, Director, 10%+ Owner
Signature
William L. Demers, by Power of Attorney for Allan C. Silber
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5/A - Amendment
Filing time
17 Mar 2022, 19:20:11 UTC
Date Of Original Report
14 Feb 2022
Previous filing
03 Sep 2021
Next filing
31 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PNT Common Stock 538,087 31 Dec 2021 Trustee F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 5 is being amended to remove the previously reported transaction involving the shares of Common Stock held indirectly by the Reporting Person as trustee, which was included in error, and to correct the number of shares of Common Stock held indirectly by the Reporting Person as trustee.
F2 Held in a trust for which the Reporting Person is the trustee.